Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy

[1]  J. Shah,et al.  NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  J. Hua,et al.  Differential detection of metastatic and inflammatory lymph nodes using inflow-based vascular-space-occupancy (iVASO) MR imaging. , 2021, Magnetic resonance imaging.

[3]  H. Nia,et al.  Solid stress impairs lymphocyte infiltration into lymph-node metastases , 2021, Nature Biomedical Engineering.

[4]  A. King,et al.  Nasopharyngeal carcinoma: an evolving paradigm , 2021, Nature Reviews Clinical Oncology.

[5]  N. S. van den Berg,et al.  Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW , 2021, Theranostics.

[6]  T. Fehm,et al.  Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard , 2021, The Journal of Nuclear Medicine.

[7]  Y. Mao,et al.  Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems. , 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  P. Høilund-Carlsen,et al.  Diagnostic accuracy of imaging modalities in detection of histopathological extranodal extension: A systematic review and meta-analysis. , 2021, Oral oncology.

[9]  R. Sun,et al.  Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I–II nasopharyngeal carcinoma: a nest case-control study , 2021, European Radiology.

[10]  N. S. van den Berg,et al.  Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody–Dye Conjugate , 2020, The Journal of Nuclear Medicine.

[11]  R. Mukherjee,et al.  Lymph node extracapsular extension as a marker of aggressive phenotype: Classification, prognosis and associated molecular biomarkers. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  F. Bootz,et al.  A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients , 2020, The Journal of Nuclear Medicine.

[13]  S. Morrison,et al.  Lymph protects metastasizing melanoma cells from ferroptosis , 2020, Nature.

[14]  W. Yarbrough,et al.  Multi-Institutional Validation of Deep Learning for Pretreatment Identification of Extranodal Extension in Head and Neck Squamous Cell Carcinoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Shanshan Huang,et al.  Label-Free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-Guided Surgery by Photoacoustic Imaging , 2019, The Journal of Nuclear Medicine.

[16]  Bin Zhang,et al.  In vivo three-dimensional evaluation of tumour hypoxia in nasopharyngeal carcinomas using FMT-CT and MSOT , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[17]  N. S. van den Berg,et al.  Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer , 2019, Nature Communications.

[18]  Joaquim M Farinhas,et al.  Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection. , 2019, JAMA otolaryngology-- head & neck surgery.

[19]  V. Lowe,et al.  Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Koh,et al.  Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation , 2019, Science.

[21]  T. Werner,et al.  Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis , 2019, Molecular Imaging and Biology.

[22]  C. Terhaard,et al.  Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  S. Stacker,et al.  Exit Stage Left: A Tumor Cell's Journey from Lymph Node to Beyond. , 2018, Trends in cancer.

[24]  R. Weber,et al.  NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[25]  Eelco F. J. Meijer,et al.  Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice , 2018, Science.

[26]  Ying Sun,et al.  Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. , 2018, The Lancet. Oncology.

[27]  E. Rosenthal,et al.  Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer , 2017, Clinical Cancer Research.

[28]  Jianlin Shi,et al.  Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia. , 2017, Chemical reviews.

[29]  Brian O'Sullivan,et al.  Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[30]  D. Neri,et al.  Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma , 2016, Molecular Cancer Therapeutics.

[31]  E. Rankin,et al.  Hypoxic control of metastasis , 2016, Science.

[32]  Guohua Shen,et al.  18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis , 2016, The Journal of Nuclear Medicine.

[33]  Soo Min Koo,et al.  Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor , 2015, Oncotarget.

[34]  L. Yin,et al.  ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[35]  P. Schneider,et al.  Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation. , 2015, Nature chemistry.

[36]  Konstantin V Sokolov,et al.  Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. , 2014, Cancer research.

[37]  J. Petersen,et al.  Imaging hypoxia to improve radiotherapy outcome , 2012, Nature Reviews Clinical Oncology.

[38]  A. Earnest,et al.  Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence , 2012, BMC Cancer.

[39]  R. Gillies,et al.  Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes , 2011, Clinical Cancer Research.

[40]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[41]  S. Leung,et al.  Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer research.

[42]  Xin Lu,et al.  In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. , 2010, Cancer research.

[43]  K. Owzar,et al.  Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  A. Harris,et al.  Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  A. Harris,et al.  Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[47]  Zhiyou Wu,et al.  Label-free Visualization of Early Cancer Hepatic Micrometastasis and Intraoperative Image-guided Surgery by Photoacoustic Imaging , 2019 .

[48]  18F-FDG PET/CT for the diagnosis of residual or recurrent nasopharyngeal carcinoma after radiotherapy: a meta-analysis , 2015 .